Medication info
Sitifor Tablet 50mg (Sitagliptin Hydrochloride Monohydrate)

Sitifor Tablet 50mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.69mg / 1 tablet
Manufacturer / importer
Donggwang Pharma Co., Ltd.
Appearance
Bright yellow-orange round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202102608 · Approved 2021.03.25 · Insurance code 645907170

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This medicine is administered at 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is necessary, assessment of renal function is recommended before and periodically during treatment with this medicine. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Donggwang Pharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used alongside diet and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. For patients without prior experience in diabetes medication treatment and who find it difficult to control blood sugar alone, it can be taken in combination with Metformin. Additionally, when blood sugar control is insufficient with monotherapy using sulfonylureas, Metformin, thiazolidinediones, or insulin, this drug is used in combination. When it is difficult to control blood sugar with multiple medication combinations, this drug can be added to enhance therapeutic efficacy. It is used to improve blood sugar control tailored to various treatment situations.

Dosage and Administration

Adult dosage

This medicine is administered at 100 mg once daily, either as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is necessary, assessment of renal function is recommended before and periodically during treatment with this medicine. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication can cause serious allergic reactions, so if symptoms such as skin rash or difficulty breathing occur, you should stop taking it immediately and consult a doctor. Also, severe pancreatitis, a serious inflammation of the pancreas, may occur, so if symptoms like abdominal pain, vomiting, or decreased appetite appear during treatment, you should visit a hospital immediately. Patients with type 1 diabetes or those with specific allergic reactions should not take this medication. Patients with impaired kidney function may need dosage adjustments, and it is important to have regular kidney function tests both before and during treatment. This medication can be used alone or in combination with other diabetes treatments, and when combined, there may be an increased risk of hypoglycemia, so changes in blood sugar should be carefully monitored. During treatment with this drug, side effects such as headaches, upper respiratory infections, nasopharyngitis, diarrhea, abdominal pain, nausea, constipation, muscle pain, limb pain, back pain, pruritus, thrombocytopenia, dizziness, indigestion, gastritis, weight loss, hypertension, hypernatremia, and erectile dysfunction may occur, so if symptoms are severe, you should consult a doctor. Severe joint pain or skin blistering may occur, so if these symptoms arise, treatment should be stopped immediately and a specialist should be consulted. It is recommended that women who are pregnant or breastfeeding do not take this medication, and safety in children and adolescents under 18 years of age has not been established. Elderly patients may have reduced kidney function, so dosage adjustments and kidney function tests are even more important. In cases of overdose, general emergency treatment should be provided, and blood dialysis may be necessary to remove this medication if needed. There are relatively few drug interactions, but caution should be exercised when used with specific medications under a doctor's guidance.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 30 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • vesicular pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • elevated low-density lipoprotein
  • hyperglycemia
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tight container to prevent exposure to air and moisture. It is best to maintain storage temperatures between 1 and 30 degrees Celsius. Doing so will help maintain the effectiveness of the medication and prevent degradation.

Appearance and packaging

Appearance

Bright yellow-orange round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.